149 related articles for article (PubMed ID: 21145833)
1. Direct effects of iodothyronines on excess fat storage in rat hepatocytes.
Grasselli E; Voci A; Canesi L; De Matteis R; Goglia F; Cioffi F; Fugassa E; Gallo G; Vergani L
J Hepatol; 2011 Jun; 54(6):1230-6. PubMed ID: 21145833
[TBL] [Abstract][Full Text] [Related]
2. Non-receptor-mediated actions are responsible for the lipid-lowering effects of iodothyronines in FaO rat hepatoma cells.
Grasselli E; Voci A; Canesi L; Goglia F; Ravera S; Panfoli I; Gallo G; Vergani L
J Endocrinol; 2011 Jul; 210(1):59-69. PubMed ID: 21508094
[TBL] [Abstract][Full Text] [Related]
3. Reduced expression of peroxisome proliferator-activated receptor-alpha may have an important role in the development of non-alcoholic fatty liver disease.
Yeon JE; Choi KM; Baik SH; Kim KO; Lim HJ; Park KH; Kim JY; Park JJ; Kim JS; Bak YT; Byun KS; Lee CH
J Gastroenterol Hepatol; 2004 Jul; 19(7):799-804. PubMed ID: 15209628
[TBL] [Abstract][Full Text] [Related]
4. Underlying mechanisms of pharmacology and toxicity of a novel PPAR agonist revealed using rodent and canine hepatocytes.
Guo Y; Jolly RA; Halstead BW; Baker TK; Stutz JP; Huffman M; Calley JN; West A; Gao H; Searfoss GH; Li S; Irizarry AR; Qian HR; Stevens JL; Ryan TP
Toxicol Sci; 2007 Apr; 96(2):294-309. PubMed ID: 17255113
[TBL] [Abstract][Full Text] [Related]
5. PAT protein mRNA expression in primary rat hepatocytes: Effects of exposure to fatty acids.
Grasselli E; Voci A; Pesce C; Canesi L; Fugassa E; Gallo G; Vergani L
Int J Mol Med; 2010 Apr; 25(4):505-12. PubMed ID: 20198297
[TBL] [Abstract][Full Text] [Related]
6. PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes.
Seo YS; Kim JH; Jo NY; Choi KM; Baik SH; Park JJ; Kim JS; Byun KS; Bak YT; Lee CH; Kim A; Yeon JE
J Gastroenterol Hepatol; 2008 Jan; 23(1):102-9. PubMed ID: 18171348
[TBL] [Abstract][Full Text] [Related]
7. Compound K modulates fatty acid-induced lipid droplet formation and expression of proteins involved in lipid metabolism in hepatocytes.
Kim MS; Lee KT; Iseli TJ; Hoy AJ; George J; Grewal T; Roufogalis BD
Liver Int; 2013 Nov; 33(10):1583-93. PubMed ID: 23998390
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes.
Ricchi M; Odoardi MR; Carulli L; Anzivino C; Ballestri S; Pinetti A; Fantoni LI; Marra F; Bertolotti M; Banni S; Lonardo A; Carulli N; Loria P
J Gastroenterol Hepatol; 2009 May; 24(5):830-40. PubMed ID: 19207680
[TBL] [Abstract][Full Text] [Related]
9. 3,5-Diiodo-L-thyronine modulates the expression of genes of lipid metabolism in a rat model of fatty liver.
Grasselli E; Voci A; Demori I; Canesi L; De Matteis R; Goglia F; Lanni A; Gallo G; Vergani L
J Endocrinol; 2012 Feb; 212(2):149-58. PubMed ID: 22107956
[TBL] [Abstract][Full Text] [Related]
10. The natural carotenoid astaxanthin, a PPAR-α agonist and PPAR-γ antagonist, reduces hepatic lipid accumulation by rewiring the transcriptome in lipid-loaded hepatocytes.
Jia Y; Kim JY; Jun HJ; Kim SJ; Lee JH; Hoang MH; Hwang KY; Um SJ; Chang HI; Lee SJ
Mol Nutr Food Res; 2012 Jun; 56(6):878-88. PubMed ID: 22707263
[TBL] [Abstract][Full Text] [Related]
11. Effect of medium- and long-chain fatty acid diets on PPAR and SREBP-1 expression and glucose homeostasis in ACBP-overexpressing transgenic rats.
Oikari S; Ahtialansaari T; Huotari A; Kiehne K; Fölsch UR; Wolffram S; Jänne J; Alhonen L; Herzig KH
Acta Physiol (Oxf); 2008 Sep; 194(1):57-65. PubMed ID: 18394026
[TBL] [Abstract][Full Text] [Related]
12. 3,5-diiodothyronine mimics the effect of triiodothyronine on insulin-like growth factor binding protein-4 expression in cultured rat hepatocytes.
Demori I; Gerdoni E; Fugassa E; Voci A
Horm Metab Res; 2004 Oct; 36(10):679-85. PubMed ID: 15523592
[TBL] [Abstract][Full Text] [Related]
13. Importance of PPAR alpha for the effects of growth hormone on hepatic lipid and lipoprotein metabolism.
Ljungberg A; Lindén D; Améen C; Bergström G; Oscarsson J
Growth Horm IGF Res; 2007 Apr; 17(2):154-64. PubMed ID: 17307376
[TBL] [Abstract][Full Text] [Related]
14. Fatty liver and anti-oxidant enzyme activities along with peroxisome proliferator-activated receptors γ and α expressions in the liver of Wilson's disease.
Nagasaka H; Miida T; Inui A; Inoue I; Tsukahara H; Komatsu H; Hiejima E; Fujisawa T; Yorifuji T; Hiranao K; Okajima H; Inomata Y
Mol Genet Metab; 2012 Nov; 107(3):542-7. PubMed ID: 22940187
[TBL] [Abstract][Full Text] [Related]
15. Silybin counteracts lipid excess and oxidative stress in cultured steatotic hepatic cells.
Vecchione G; Grasselli E; Voci A; Baldini F; Grattagliano I; Wang DQ; Portincasa P; Vergani L
World J Gastroenterol; 2016 Jul; 22(26):6016-26. PubMed ID: 27468193
[TBL] [Abstract][Full Text] [Related]
16. Pycnogenol® inhibits lipid accumulation in 3T3-L1 adipocytes with the modulation of reactive oxygen species (ROS) production associated with antioxidant enzyme responses.
Lee OH; Seo MJ; Choi HS; Lee BY
Phytother Res; 2012 Mar; 26(3):403-11. PubMed ID: 21796705
[TBL] [Abstract][Full Text] [Related]
17. Changes in expression levels of genes involved in fatty acid metabolism: upregulation of all three members of the PPAR family (alpha, gamma, delta) and the newly described adiponectin receptor 2, but not adiponectin receptor 1 during neonatal cardiac development of the rat.
Steinmetz M; Quentin T; Poppe A; Paul T; Jux C
Basic Res Cardiol; 2005 May; 100(3):263-9. PubMed ID: 15754086
[TBL] [Abstract][Full Text] [Related]
18. Chronic, in vivo, PPARalpha activation prevents lipid overload in rat liver induced by high fat feeding.
Wierzbicki M; Chabowski A; Zendzian-Piotrowska M; Harasim E; Górski J
Adv Med Sci; 2009; 54(1):59-65. PubMed ID: 19403437
[TBL] [Abstract][Full Text] [Related]
19. Regulation of peroxisome proliferator-activated receptor-alpha mRNA in rat liver.
Sterchele PF; Sun H; Peterson RE; Vanden Heuvel JP
Arch Biochem Biophys; 1996 Feb; 326(2):281-9. PubMed ID: 8611035
[TBL] [Abstract][Full Text] [Related]
20. Docosahexaenoic acid membrane content and mRNA expression of acyl-CoA oxidase and of peroxisome proliferator-activated receptor-delta are modulated in Y79 retinoblastoma cells differently by low and high doses of alpha-linolenic acid.
Langelier B; Furet JP; Perruchot MH; Alessandri JM
J Neurosci Res; 2003 Oct; 74(1):134-41. PubMed ID: 13130515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
